Dual and selective inhibitors of pteridine reductase 1 (PTR1) and dihydrofolate reductase-thymidylate synthase (DHFR-TS) from Leishmania chagasi

References

• Ready PD. Epidemiology of visceral leishmaniasis. Clin Epidemiol 2014;6:147–54.
   PubMed Web of Science ®Google Scholar
• Nagle AS, Khare S, Kumar AB, et al. Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis. Chem Rev 2014;114:11305–47.
   PubMed Web of Science ®Google Scholar
• Croft SL, Barrett MP, Urbina JA. Chemotherapy of trypanosomiases and leishmaniasis. Trends Parasitol 2005;21:508–12.
   PubMed Web of Science ®Google Scholar
• Croft SL, Olliaro P. Leishmaniasis chemotherapy—challenges and opportunities. Clin Microbiol Infect 2011;17:1478–83.
   PubMed Web of Science ®Google Scholar
• De Menezes JPB, Guedes CES, De Oliveira AL, et al. Advances in development of new treatment for leishmaniasis. Biomed Res Int 2015;2015:15–18.
   Web of Science ®Google Scholar
• Field MC, Horn D, Fairlamb AH, et al. Antitrypanosomatid drug discovery: an ongoing challenge and a continuing need. Nat Rev Microbiol 2017;15:217–31.
   PubMed Web of Science ®Google Scholar
• Cardoso VS, Vermelho AB, Ricci Junior E, et al. Antileishmanial activity of sulphonamide nanoemulsions targeting the b-carbonic anhydrase from Leishmania species. J Enzym Inhib Med Chem 2018;33:850–7.
   PubMed Web of Science ®Google Scholar
• Nocentini A, Cadoni R, Dumy P, et al. Carbonic anhydrases from Trypanosoma cruzi and Leishmania donovani chagasi are inhibited by benzoxaboroles. J Enzyme Inhib Med Chem 2018;55:286–9.
   Web of Science ®Google Scholar
• Vermelho AB, Capaci GR, Rodrigues IA, et al. Carbonic anhydrases from Trypanosoma and Leishmania as anti-protozoan drug targets. Bioorg Med Chem 2017;25:1543–55.
   PubMed Web of Science ®Google Scholar
• Garcia AR, Oliveira DMP, Amaral ACF, et al. Leishmania infantum arginase: biochemical characterization and inhibition by naturally occurring phenolic substances. J Enzyme Inhib Med Chem 2019;34:1100–9.
   PubMed Web of Science ®Google Scholar
• Adinehbeigi K, Razi Jalali MH, Shahriari A, Bahrami S. In vitro antileishmanial activity of fisetin flavonoid via inhibition of glutathione biosynthesis and arginase activity in Leishmania infantum. Pathog Glob Health 2017;111:176–85.
   PubMed Web of Science ®Google Scholar
• Martin-Montes A, Santivañez-Veliz M, Moreno-Viguri E, et al. In vitro antileishmanial activity and iron superoxide dismutase inhibition of arylamine Mannich base derivatives. Parasitology 2017;114:1783–90.
   Web of Science ®Google Scholar
• Martínez VC, Vera M. Therapeutic potential of pteridine derivatives : a comprehensive review. Med Res Rev 2018;1–56.
   Web of Science ®Google Scholar
• Linciano P, Dawson A, Po I, et al. Exploiting the 2 – Amino-1,3,4-thiadiazole scaffold to inhibit Trypanosoma brucei pteridine reductase in support of early-stage drug discovery. ACS Omega 2017; 2:5666–83.
   PubMed Web of Science ®Google Scholar
• Leite FHA, Santiago PBG, da S, Froes TQ, et al. Structure-guided discovery of thiazolidine-2,4-dione derivatives as a novel class of Leishmania major pteridine reductase 1 inhibitors. Eur J Med Chem 2016;123:639–48.
   PubMed Web of Science ®Google Scholar
• Romero AH, Rodríguez N, Oviedo H. 2-Aryl-quinazolin-4 (3 H) -ones as an inhibitor of leishmania folate pathway: in vitro biological evaluation, mechanism studies and molecular docking. Bioorganic Chemistry 2019;83:145–53.
   PubMed Web of Science ®Google Scholar
• Vickers TJ, Beverley SM. Folate metabolic pathways in Leishmania. Essays Biochem 2011;51:63–80.
   PubMed Web of Science ®Google Scholar
• Gatton ML, Martin LB, Cheng Q. Evolution of resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum. Antimicrob Agents Chemother 2004;48:2116–23.
   PubMed Web of Science ®Google Scholar
• Sharma D, Lather M, Mallick PK, et al. Polymorphism in drug resistance genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium falciparum in some states of India. Parasit and Vectors [Internet] 2015;8:1–9.
   PubMed Web of Science ®Google Scholar
• Munita JM, Arias CA. Mechanisms of antibiotic resistance. Microbiol Spectr 2016;4:80–7.
   Web of Science ®Google Scholar
• Ivanetich K, Santi D. Thymidylate synthase-dihydrofolate reductase in protozoa. Exp Parasitol. 1990;70(3):367–71.
   Google Scholar
• Nare B, Luba J, Hardy LW, Beverley S. New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity. Parasitology 1997;114:S101–S10.
   PubMed Web of Science ®Google Scholar
• Luba J, Nare B, Liang PH, et al. Leishmania major pteridine reductase 1 belongs to the short chain dehydrogenase family: stereochemical and kinetic evidence. Biochemistry 1998;37:4093–104.
   PubMed Web of Science ®Google Scholar
• Hardy LW, Matthews W, Nare B, Beverley SM. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways. Exp Parasitol 1997;87:157–69.
   PubMed Web of Science ®Google Scholar
• Leite FHA, Froes TQ, da Silva SG, et al. An integrated approach towards the discovery of novel non-nucleoside Leishmania major pteridine reductase 1 inhibitors. Eur J Med Chem 2017;132:322–32.
   PubMed Web of Science ®Google Scholar
• Barrack KL, Tulloch LB, Burke LA, et al. Structure of recombinant Leishmania donovani pteridine reductase reveals a disordered active site. Acta Crystallogr Sect F Struct Biol Cryst Commun 2011;67:33–7.
   PubMedGoogle Scholar
• Teles ALB, Silva RR, Ko M, et al. Identification, characterization and molecular modelling studies of Schistosoma mansoni dihydrofolate reductase inhibitors: from assay development to hit identification. Curr Top Med Chem 2018;18:406–17.
   PubMed Web of Science ®Google Scholar
• Sambrook J, Russel D, Molecular cloning. 3rd ed. New York: Cold Spring Harbor Laboratory; 2001.
   Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–54.
   PubMed Web of Science ®Google Scholar
• Wingfield PT. Protein precipitation using ammonium sulfate. Curr Protoc Protein Sci 2001;Appendix–3F:1–10.
   Google Scholar
• Meek TD, Garvey EP, Santi DV. Purification and characterization of the bifunctional thymidylate synthetase-dihydrofolate reductase from methotrexate-resistant Leishmania tropica. Biochemistry 1985;24:678–86.
   PubMed Web of Science ®Google Scholar
• Dawson A, Gibellini F, Sienkiewicz N, et al. Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate. Mol Microbiol 2006;61:1457–68.
   PubMed Web of Science ®Google Scholar
• Copeland RA. Evaluation of enzyme inhibitors in drug discovery: a guide for medicinal chemists and pharmacologists. 1st ed. United States of America: Wiley-interscience; 2005.
   Google Scholar
• Kumar P, Kothari H, Singh N. Overexpression in Escherichia coli and purification of pteridine reductase (PTR1) from a clinical isolate of Leishmania donovani. Protein Expr Purif 2004;38:228–36.
   PubMed Web of Science ®Google Scholar
• Booth WT, Schlachter CR, Pote S, et al. Impact of an N-terminal polyhistidine tag on protein thermal stability. ACS Omega 2018;3:760–8.
   PubMed Web of Science ®Google Scholar
• Gourley DG, Luba J, Hardy LW, et al. Crystallization of recombinant Leishmania major pteridine reductase 1 (PTR1). Acta Crystallogr Sect D Biol Crystallogr 1999;55:1608–10.
   PubMedGoogle Scholar
• Osorio E, Aguilera C, Naranjo N, et al. Biochemical characterization of the bifunctional enzyme dihydrofolate reductase-thymidylate synthase from Leishmania (Viannia) and its evaluation as a drug target. Biomedica 2013;33:393–401.
   PubMed Web of Science ®Google Scholar
• Senkovich O, Schormann N, Chattopadhyay D. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate. Acta Crystallogr Sect D Biol Crystallogr 2009;65:704–16.
   PubMedGoogle Scholar
• Grumont R, Sirawaraporn W, Santi DV. Heterologous expression of the bifunctional thymidylate synthase-dihydrofolate reductase from Leishmania major. Biochemistry 1988;27:3776–84.
   PubMed Web of Science ®Google Scholar
• Ferrer M, Chernikova TN, Yakimov MM, et al. Chaperonins govern growth of Escherichia coli at low temperatures. Nat Biotechnol 2003;21:1266–7.
   PubMed Web of Science ®Google Scholar
• Reche P, Arrebola R, Olmo A, et al. Cloning and expression of the dihydrofolate reductase-thymidylate synthase gene from Trypanosoma cruzi. Mol Biochem Parasitol 1994;65:247–58.
   PubMed Web of Science ®Google Scholar
• Gibson MW, Dewar S, Ong HB, et al. Trypanosoma brucei DHFR-TS revisited: characterisation of a bifunctional and highly unstable recombinant dihydrofolate reductase-thymidylate synthase. PLoS Negl Trop Dis 2016;10:e0004714–20.
   PubMed Web of Science ®Google Scholar
• Bisswanger H. Enzyme assays. Perspectives Sci. 2014;1(1):41–55.
   Google Scholar
• Glaser TA, Baatz JE, Kreishman GP, Mukkada AJ. pH homeostasis in Leishmania donovani amastigotes and promastigotes. Proc Natl Acad Sci USA 1988;85:7602–6.
   PubMed Web of Science ®Google Scholar
• Yu PL, Zhao J, Yu M, et al. Functional expression of the dihydrofolate reductase domain of Leishmania major dihydrofolate reductase-thymidylate synthase bifunctional protein. Protein Expr Purif 1996;8:23–7.
   PubMed Web of Science ®Google Scholar
• Tahar R, De Pécoulas PE, Basco LK, et al. Kinetic properties of dihydrofolate reductase from wild-type and mutant Plasmodium vivax expressed in Escherichia coli. Mol Biochem Parasitol 2001;113:241–9.
   PubMed Web of Science ®Google Scholar
• Pattanakitsakul S, Ruenwongsa P. Characterization of thymidylate synthetase and dihydrofolate reductase from Plasmodium berghei. Int J Parasitol 1984;14:513–20.
   PubMed Web of Science ®Google Scholar
• Beard WA, Appleman JR, Delcamp TJ, et al. The wide range of rates exhibited. J Biol 1989;264:9391–9.
   Google Scholar
• Liu CT, Francis K, Layfield JP, et al. Escherichia coli dihydrofolate reductase catalyzed proton and hydride transfers: temporal order and the roles of Asp27 and Tyr100. Proc Natl Acad Sci 2014;111:18231–6.
   PubMed Web of Science ®Google Scholar
• Acker MG, Auld DS. Considerations for the design and reporting of enzyme assays in high-throughput screening applications. Perspect Sci 2014;1:56–73.
   Google Scholar
• Liang PH, Anderson KS. Substrate channeling and domain-domain interactions in bifunctional thymidylate synthase-dihydrofolate reductase. Biochemistry 1998;37:12195–205.
   PubMed Web of Science ®Google Scholar
• Copeland RA, Enzymes-a practical introduction to structure. 2nd ed. New York: J Wiley-Interscience; 2000.
   Google Scholar
• Kaur J, Sundar S, Singh N. Molecular docking, structure–activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani. Antimicro Agents Chemother 2010;65:1742–8.
   Web of Science ®Google Scholar
• Kaur J, Kumar P, Tyagi S, et al. In silico screening, structure-activity relationship, and biologic evaluation of selective pteridine reductase inhibitors targeting visceral leishmaniasis. Antimicro Agents Chemother 2011;55:659–66.
   PubMed Web of Science ®Google Scholar
• Chang C, Bray T, Whiteley JM. Mutant PTR1 proteins from Leishmania tarentolae : comparative kinetic properties and active-site labeling. Arch Biochem Biophys. 1999;368:161–71.
   PubMed Web of Science ®Google Scholar
• Nare B, Hardy LW, Stephen M, et al. The roles of pteridine reductase 1 and synthase in pteridine metabolism in the protozoan parasite Leishmania major. Biol Chem 1997;272:13883–91.
   Web of Science ®Google Scholar
• Brodelius PE. Enzyme assays. Curr Opin Biotechnol 1991;2:23–9.
   PubMed Web of Science ®Google Scholar
• Caldwell GW, Yan Z, Lang W, Masucci JA. The IC(50) concept revisited. Curr Top Med Chem 2012;12:1282–90.
   PubMed Web of Science ®Google Scholar
• Stone SR, Morrison JF. Dihydrofolate reductase from Escherichia coli: the kinetic mechanism with NADPH and reduced acetylpyridine adenine dinucleotide phosphate as substrates. Biochemistry 1988;27:5493–9.
   PubMed Web of Science ®Google Scholar
• Nammalwar B, Bunce RA, Berlin KD, et al. Microwave-assisted heck synthesis of substituted 2,4-diaminopyrimidine- based antibiotics. Org Prep Proced Int 2012;44:281–7.
   PubMed Web of Science ®Google Scholar